Adage Capital Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.96M | Buy |
2,575,941
+1,000,000
| +63% | +$3.09M | 0.01% | 654 |
|
|
2025
Q1 | $5.5M | Sell |
1,575,941
-75,000
| -5% | -$262K | 0.01% | 684 |
|
|
2024
Q4 | $5.4M | Sell |
1,650,941
-1,250,000
| -43% | -$4.09M | 0.01% | 710 |
|
|
2024
Q3 | $11.2M | Sell |
2,900,941
-99,059
| -3% | -$381K | 0.02% | 586 |
|
|
2024
Q2 | $9.27M | Hold |
3,000,000
| – | – | 0.02% | 618 |
|
|
2024
Q1 | $7.74M | Buy |
+3,000,000
| New | +$7.74M | 0.01% | 641 |
|